329 related articles for article (PubMed ID: 16545113)
1. Neutropenia induced in outbred mice by a simplified low-dose cyclophosphamide regimen: characterization and applicability to diverse experimental models of infectious diseases.
Zuluaga AF; Salazar BE; Rodriguez CA; Zapata AX; Agudelo M; Vesga O
BMC Infect Dis; 2006 Mar; 6():55. PubMed ID: 16545113
[TBL] [Abstract][Full Text] [Related]
2. Contribution of alveolar phagocytes to antibiotic efficacy in an experimental lung infection with Streptococcus pneumoniae.
Calame W; Douwes-Idema AE; van den Barselaar MT; Mattie H
J Infect; 2001 May; 42(4):235-42. PubMed ID: 11545565
[TBL] [Abstract][Full Text] [Related]
3. Enhanced clearance of Escherichia coli and Staphylococcus aureus in mice treated with cyclophosphamide and lactoferrin.
Artym J; Zimecki M; Kruzel ML
Int Immunopharmacol; 2004 Sep; 4(9):1149-57. PubMed ID: 15251111
[TBL] [Abstract][Full Text] [Related]
4. Broad-spectrum antimicrobial efficacy of peptide A3-APO in mouse models of multidrug-resistant wound and lung infections cannot be explained by in vitro activity against the pathogens involved.
Ostorhazi E; Holub MC; Rozgonyi F; Harmos F; Cassone M; Wade JD; Otvos L
Int J Antimicrob Agents; 2011 May; 37(5):480-4. PubMed ID: 21353493
[TBL] [Abstract][Full Text] [Related]
5. Pathophysiology of in-vitro induced filaments, spheroplasts and rod-shaped bacteria in neutropenic mice.
Buijs J; Dofferhoff AS; Mouton JW; van der Meer JW
Clin Microbiol Infect; 2006 Nov; 12(11):1105-11. PubMed ID: 17002610
[TBL] [Abstract][Full Text] [Related]
6. Pharmacodynamics of moxifloxacin and levofloxacin against Streptococcus pneumoniae, Staphylococcus aureus, Klebsiella pneumoniae and Escherichia coli: simulation of human plasma concentrations after intravenous dosage in an in vitro kinetic model.
Odenholt I; Cars O
J Antimicrob Chemother; 2006 Nov; 58(5):960-5. PubMed ID: 16936293
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of rigidly-linked vancomycin dimers and their in vivo efficacy against resistant bacteria.
Lu J; Yoshida O; Hayashi S; Arimoto H
Chem Commun (Camb); 2007 Jan; (3):251-3. PubMed ID: 17299629
[TBL] [Abstract][Full Text] [Related]
8. In vivo pharmacodynamics of lefamulin, the first systemic pleuromutilin for human use, in a neutropenic murine thigh infection model.
Wicha WW; Craig WA; Andes D
J Antimicrob Chemother; 2019 Apr; 74(Suppl 3):iii5-iii10. PubMed ID: 30949706
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of telavancin in a murine model of bacteraemia induced by methicillin-resistant Staphylococcus aureus.
Reyes N; Skinner R; Benton BM; Krause KM; Shelton J; Obedencio GP; Hegde SS
J Antimicrob Chemother; 2006 Aug; 58(2):462-5. PubMed ID: 16735425
[TBL] [Abstract][Full Text] [Related]
10. Enhanced efficacy of single-dose versus multi-dose azithromycin regimens in preclinical infection models.
Girard D; Finegan SM; Dunne MW; Lame ME
J Antimicrob Chemother; 2005 Aug; 56(2):365-71. PubMed ID: 16002421
[TBL] [Abstract][Full Text] [Related]
11. Lysostaphin as a treatment for systemic Staphylococcus aureus infection in a mouse model.
Kokai-Kun JF; Chanturiya T; Mond JJ
J Antimicrob Chemother; 2007 Nov; 60(5):1051-9. PubMed ID: 17848374
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of the amphibian peptide distinctin in a neutropenic mouse model of staphylococcal sepsis.
Cirioni O; Ghiselli R; Orlando F; Silvestri C; De Luca S; Salzano AM; Mocchegiani F; Saba V; Scalise G; Scaloni A; Giacometti A
Crit Care Med; 2008 Sep; 36(9):2629-33. PubMed ID: 18679116
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics/pharmacodynamics of antofloxacin hydrochloride in a neutropenic murine thigh model of Staphylococcus aureus infection.
Xiao XM; Xiao YH
Acta Pharmacol Sin; 2008 Oct; 29(10):1253-60. PubMed ID: 18817632
[TBL] [Abstract][Full Text] [Related]
14. Development and validation of a multi-dose neutropenic rat thigh infection model using real-time monitoring of Staphylococcus aureus growth in vivo.
Zhang H; Kalkeri G; Mani N; Grossman TH
In Vivo; 2008; 22(6):667-72. PubMed ID: 19180989
[TBL] [Abstract][Full Text] [Related]
15. Nucleoside-nucleotide mixture increases peripheral neutrophils in cyclophosphamide-induced neutropenic mice.
Matsumoto Y; Adjei AA; Yamauchi K; Kise M; Yokoyama H; Shinagawa Y; Yamamoto S
Nutrition; 1995; 11(3):296-9. PubMed ID: 8541701
[TBL] [Abstract][Full Text] [Related]
16. Oral anti-pneumococcal activity and pharmacokinetic profiling of a novel peptide deformylase inhibitor.
Gross M; Clements J; Beckett RP; Thomas W; Taylor S; Lofland D; Ramanathan-Girish S; Garcia M; Difuntorum S; Hoch U; Chen H; Johnson KW
J Antimicrob Chemother; 2004 Mar; 53(3):487-93. PubMed ID: 14963065
[TBL] [Abstract][Full Text] [Related]
17. Cyclophosphamide (Cytoxan)-induced hematologic alterations in specific-pathogen-free chickens.
Fulton RM; Reed WM; Thacker HL; DeNicola DB
Avian Dis; 1996; 40(1):1-12. PubMed ID: 8713021
[TBL] [Abstract][Full Text] [Related]
18. Protective effects of plasmin(ogen) in a mouse model of Staphylococcus aureus-induced arthritis.
Guo Y; Li J; Hagström E; Ny T
Arthritis Rheum; 2008 Mar; 58(3):764-72. PubMed ID: 18311818
[TBL] [Abstract][Full Text] [Related]
19. Potency of DX-619, a novel des-F(6)-quinolone, in haematogenous murine bronchopneumonia caused by methicillin-resistant and vancomycin-intermediate Staphylococcus aureus.
Yanagihara K; Seki M; Izumikawa K; Higashiyama Y; Miyazaki Y; Hirakata Y; Tomono K; Mizuta Y; Tsukamoto K; Kohno S
Int J Antimicrob Agents; 2006 Sep; 28(3):212-6. PubMed ID: 16887340
[TBL] [Abstract][Full Text] [Related]
20. [Changes and significance of peripheral blood platelet count in tumor shrinkage induced by a low dose of CTX in T739 mice].
Li ML; Jia YJ; Jiang MN; Shu XH; Li CG
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Jun; 24(6):567-9. PubMed ID: 18538085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
